Macquarie Group LTD Simulations Plus, Inc. Transaction History

Macquarie Group LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$47.75 - $66.88 $12,844 - $17,990	-269 Closed	0 $13,000
Q2 2021 Aug 13, 2021	SELL	$49.67 - $68.96 $8,592 - $11,930	-173 Reduced 39.14%	269 $15,000
Q1 2021 May 14, 2021	SELL	$60.06 - $89.52 $88,108 - $131,325	-1,467 Reduced 76.85%	442 $28,000
Q4 2020 Feb 16, 2021	BUY	$53.26 - $77.18 $90,115 - $130,588	1,692 Added 779.72%	1,909 $137,000
Q2 2020 Aug 11, 2020	BUY	$32.91 - $59.82 $7,141 - $12,980	217 New	217 $13,000
Q4 2018 Feb 15, 2019	SELL	$17.56 - $21.2 $403 - $487	-23 Closed	0 $0
Q3 2018 Nov 15, 2018	SELL	$17.1 - $23.55 $111,851 - $154,040	-6,541 Reduced 99.65%	23 $0
Q2 2018 Aug 14, 2018	BUY	$14.65 - $23.75 $36,375 - $58,971	2,483 Added 60.84%	6,564 $146,000
Q1 2018 May 11, 2018	SELL	$14.4 - $16.8 $53,280 - $62,160	-3,700 Reduced 47.55%	4,081 $60,000
Q4 2017 Feb 15, 2018	SELL	$15.3 - $17.4 $191,999 - $218,352	-12,549 Reduced 61.73%	7,781 $125,000
Q3 2017 Nov 08, 2017	BUY	$13.7 - $15.65 $278,521 - $318,164	20,330	20,330 $315,000

176

15.2M

5.4K

1.4K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $636M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.